Trace Biosciences Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$8.33M
- Investors
-
12
Trace Biosciences General Information
Description
Developer of nerve-targeted fluorescent contrast agents designed to guide surgeries and eliminate surgical nerve damage. The company's agents provide direct highlighting of nerves during surgery in real-time and visualization of nerves buried beneath the surface with high contrast over other tissues, enabling surgeons to see and preserve nerves during critical surgeries.
Contact Information
Website
www.trace-bio.comCorporate Office
- 1800 North West
- 167th Place, Suite 160
- Beaverton, OR 97006
- United States
Corporate Office
- 1800 North West
- 167th Place, Suite 160
- Beaverton, OR 97006
- United States
Trace Biosciences Timeline
Trace Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC (Series A) | 30-Jul-2026 | $8.33M | Completed | Clinical Trials - Phase 2 | ||
| 12. Accelerator/Incubator | 01-May-2024 | Completed | Clinical Trials - Phase 2 | |||
| 11. Grant | 30-Apr-2024 | Completed | Clinical Trials - Phase 2 | |||
| 10. Grant | 01-Apr-2024 | Completed | Clinical Trials - Phase 2 | |||
| 9. Grant | 15-Sep-2023 | Completed | Startup | |||
| 8. Grant | 23-Jun-2023 | Completed | Startup | |||
| 7. Seed Round | 30-Apr-2023 | Completed | Startup | |||
| 6. Grant | 01-Oct-2022 | Completed | Startup | |||
| 5. Grant | 01-Sep-2021 | $150K | $400K | Completed | Startup | |
| 4. Grant | 01-Sep-2021 | $1.16M | $400K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Trace Biosciences Comparisons
Industry
Financing
Details
Trace Biosciences Competitors (2)
One of Trace Biosciences’s 2 competitors is Alume Biosciences, a Venture Capital-Backed company based in La Jolla, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alume Biosciences | Venture Capital-Backed | La Jolla, CA | ||||
| Illuminare Biotechnologies | Venture Capital-Backed | New York, NY |
Trace Biosciences Signals
Trace Biosciences Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Axogen | Corporation | Minority | ||
| Oregon Bioscience Incubator | Accelerator/Incubator | |||
| National Institutes of Neurological Disorders and Stroke | Government | |||
| Life Science Washington | Accelerator/Incubator | |||
| ARPA-H | Government |
Trace Biosciences FAQs
-
When was Trace Biosciences founded?
Trace Biosciences was founded in 2019.
-
Where is Trace Biosciences headquartered?
Trace Biosciences is headquartered in Beaverton, OR.
-
What is the size of Trace Biosciences?
Trace Biosciences has 10 total employees.
-
What industry is Trace Biosciences in?
Trace Biosciences’s primary industry is Surgical Devices.
-
Is Trace Biosciences a private or public company?
Trace Biosciences is a Private company.
-
What is Trace Biosciences’s current revenue?
The current revenue for Trace Biosciences is .
-
How much funding has Trace Biosciences raised over time?
Trace Biosciences has raised $9M.
-
Who are Trace Biosciences’s investors?
Axogen, Oregon Bioscience Incubator, National Institutes of Neurological Disorders and Stroke, Life Science Washington, and ARPA-H are 5 of 12 investors who have invested in Trace Biosciences.
-
Who are Trace Biosciences’s competitors?
Alume Biosciences and Illuminare Biotechnologies are competitors of Trace Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process